Skip to main content

MEDIFAST INC Value Stock - Dividend - Research Selection

Medifast inc

ISIN: US58470H1014 , WKN: 889384

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is based in Baltimore, Maryland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Medifast Announces Availability Of OPTAVIA's Comprehensive Metabolic Health System For Reimbursement On Select Insurance Plans Using Health Savings Accounts, Flexible Spending Accounts

2026-02-20
 Medifast® (NYSE: MED) today announced that OPTAVIA's comprehensive metabolic health system is available for reimbursement on select insurance plans using Health Savings Accounts (HSA) and Flexible Spending

Stephens & Co. Maintains Equal-Weight on Medifast, Lowers Price Target to $12

2026-02-19
Stephens & Co. analyst Jim Salera maintains Medifast (NYSE:MED) with a Equal-Weight and lowers the price target from $15 to $12.

Medifast Q4 2025 Earnings Call Transcript

2026-02-18

Medifast Inc (NYSE:MED) Reports Mixed Q4 Results with Deepening Losses and Challenging 2026 Outlook

2026-02-17
Medifast (MED) reports Q4 revenue beat but deep losses and weak 2026 guidance, as GLP-1 drugs pressure its weight-loss business.

Medifast, Inc. (MED) Q4 2025 Earnings Call Transcript

2026-02-17
Medifast, Inc. (MED) Q4 2025 Earnings Call February 17, 2026 4:30 PM ESTCompany ParticipantsSteven Zenker - Vice President of Investor RelationsDaniel Chard...

Medifast Sees FY2026 GAAP EPS $(2.75)-$(1.55) vs $(1.61) Est; Sees Sales $270.000M-$300.000M vs $352.100M Est

2026-02-17

Medifast Sees Q1 GAAP EPS $(0.70)-$(0.15) vs $(0.36) Est; Sees Sales $65.000M-$80.000M vs $91.300M Est

2026-02-17

Medifast Q4 EPS $(1.65) Misses $(0.82) Estimate, Sales $75.096M Beat $73.800M Estimate

2026-02-17

Earnings Scheduled For February 17, 2026

2026-02-17

What to Expect from Medifast's Earnings

2026-02-16